Search clinical trials for: SAGE-217

Total 479 results

Biogen

Terminated

A Study to Evaluate SAGE-217 for Prevention of Relapse in Adult Participants With Major Depressive Disorder

Major Depressive Disorder

United States
Biogen

Completed

A Study to Assess the Pharmacodynamic Effects of SAGE-217 in Healthy Adults Using an Insomnia Model

Healthy

United States
Biogen

Completed

A Study to Evaluate the Efficacy and Safety of SAGE-217 in Participants With Severe Postpartum Depression (PPD)

Depression, Postpartum

United States, Spain, United Kingdom
Biogen

Completed

A Study to Evaluate the Efficacy of Sage-217 in the Treatment of Adult Participants With Major Depressive Disorder (MDD)

Depressive Disorder, Major

United States
Biogen

Completed

A Study to Evaluate SAGE-217 in Participants With Severe Postpartum Depression

Postpartum Depression

United States
Sage Therapeutics
Biogen

Completed

A Study to Evaluate SAGE-217 in Adult Participants With Major Depressive Disorder (MDD)

Major Depressive Disorder

United States
Sage Therapeutics
Biogen

Recruiting

Zuranolone Pharmacokinetics (PK) and Safety Study Adolescent Participants With Major Depressive Disorder (MDD)

Major Depressive Disorder

United States
Biogen

Terminated

A Study to Evaluate the Safety, Tolerability, and Efficacy of SAGE-217 Compared to Placebo in Adult Participants With Comorbid Major Depressive Disorder (MDD) and Insomnia

Insomnia | Major Depressive Disorder

United States
Biogen

Completed

A Comparative Study of Sage-217 Plus an Antidepressant (ADT) Versus Placebo Plus an ADT in Adults With Major Depressive Disorder

Depressive Disorder, Major

United States
Biogen

Completed

A Study to Evaluate SAGE-217 in Participants With Bipolar I/II Disorder With a Current Major Depressive Episode

Bipolar Disorder I | Major Depressive Episode | Bipolar Disorder II

United States
Biogen

Completed

A Study to Evaluate the Efficacy of SAGE-217 in the Treatment of Adult Participants With Major Depressive Disorder

Major Depressive Disorder

United States
Biogen

Completed

A Study to Evaluate SAGE-217 in Participants With Moderate to Severe Major Depressive Disorder

Major Depression

United States
Biogen

Completed

A Study to Evaluate SAGE-217 in Participants With Essential Tremor

Essential Tremor

United States
Biogen

Completed

A Study to Evaluate SAGE-217 in Participants With Parkinson's Disease

Parkinson Disease

United States
Hoffmann-La Roche

Completed

A Study Comparing the Efficacy and Safety of Etrolizumab to Infliximab in Participants With Moderate to Severe Ulcerative Colitis Who Are Naïve to Tumor Necrosis Factor (TNF) Inhibitors (GARDENIA)

Ulcerative Colitis

Spain, United Kingdom, Belgium, Korea, Republic of, Austria, Czechia, France, Hungary, Italy, Netherlands, Singapore, Portugal, Canada, Germany, South Africa, Switzerland, Romania, Norway, Sweden, Israel
Inonu University

Completed

The Effect of Mindfulness-Based Pregnancy Education Program on Stress, Birth Fear and Birth Self-Efficacy in Pregnants

Stress | Pregnancy | Mindfulness | Childbirth | Midwife

Turkey
Sage Therapeutics

Recruiting

A Study to Evaluate the Long-term Safety and Tolerability of SAGE-324 in Participants With Essential Tremor

Essential Tremor

United States
Sage Therapeutics

Completed

A Study to Evaluate Safety and Efficacy of SAGE-547 in Participants With Moderate Postpartum Depression (547-PPD-202C)

Postpartum Depression

United States
University Hospital, Strasbourg, France

Completed

Research of Molecular and Metabolic Markers in Oligodendrogliomas Comparatively to Other Brain Tumours

Oligodendrogliomas

France
Sage Therapeutics

Active, not recruiting

A Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)

Mild Cognitive Impairment | Alzheimer's Disease | Mild Dementia

United States, Puerto Rico
Sage Therapeutics

Completed

A Study to Evaluate the Effects of SAGE-718 in Participants With Parkinson's Disease Cognitive Impairment

Parkinson Disease | Cognitive Dysfunction

United States
Sage Therapeutics

Completed

A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)

Cognitive Dysfunction | Alzheimer Disease | Mild Dementia

United States
Sage Therapeutics

Completed

A Study to Assess the Safety of Brexanolone in the Treatment of Adolescent Female Participants With Postpartum Depression (PPD)

Post Partum Depression

United States
Sage Therapeutics

Completed

A Study to Assess Electrophysiology, Safety, Tolerability, and Pharmacokinetics of Multiple Doses of SAGE-718 Using Ketamine Challenge in Healthy Subjects

Healthy Volunteer

United States
Sage Therapeutics

Completed

A Study to Assess the Electrophysiology, Safety, Tolerability, and Pharmacokinetics of SAGE-718 Using a Ketamine Challenge in Healthy Subjects

Healthy Volunteer

United States
Sage Therapeutics

Recruiting

A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Huntington's Disease

Huntington Disease

United States, Canada
Rennes University Hospital

Recruiting

Personalized Support Care in Alternative Midwifery Birth Units Versus Traditional Units in France : Effects on Perinatal Health and Outcomes (PhysioCare)

Compare 2 Models of Midwifery Care in Maternity Care

France
Kaiser Permanente
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

Safer Aging With Diabetes Monitoring (SAGE)

Diabetes Mellitus, Type 2 | Hypoglycemia

United States
Pfizer

Completed

A Study To Investigate The Effect Of PD-217,014 On Abdominal Pain/Discomfort In Patients With IBS.

Irritable Bowel Syndrome
Brigham and Women's Hospital
Linnaeus University

Active, not recruiting

Successful Aging and Enrichment (SAGE) (SAGE)

Healthy Aging | Cognitive Health

United States
Sage Bionetworks
Harvard Medical School (HMS and HSDM); University of Pennsylvania; New York University and other collaborators

Recruiting

Psorcast Mobile Study

Joint Pain | Psoriasis | Plaque Psoriasis | Psoriatic Arthritis | Psoriatic Nail | Dermatologic Disease | Psoriatic Conditions | Rheumatologic Disease | Dactylitis

United States
Sage Bionetworks
Robert Wood Johnson Foundation

Unknown

Mobile Parkinson Observatory for Worldwide, Evidence-based Research (mPower) (mPower)

Brain Diseases | Central Nervous System Diseases | Parkinson Disease | Parkinsonian Disorders | Basal Ganglia Diseases | Movement Disorders | Neurodegenerative Diseases

United States
Giovanna Fichera
Russell Sage College; Precision Valve Automation; St Peters Health Partners; Ann...

Not yet recruiting

Novel Splinting Technique Using 3D Models

Arthritis | Rheumatoid Arthritis | Scleroderma, Systemic | Scleroderma, Diffuse | Osteoarthritis Hand

United States
Sage Therapeutics

Recruiting

A Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington's Disease (HD)

Huntington's Disease

United States, Australia, Canada, United Kingdom
Sage Therapeutics

Completed

A Study to Evaluate the Efficacy, Safety, and Tolerability of SAGE-324 in Participants With Essential Tremor

Essential Tremor

United States
Sage Therapeutics

Active, not recruiting

28-Day Study of SAGE-718 on Functioning Capacity in Participants With Huntington's Disease

Huntington Disease

United States
Sage Therapeutics
Biogen

Active, not recruiting

Study to Evaluate SAGE-324 in Participants With Essential Tremor

Essential Tremor

United States
Sage Therapeutics

Terminated

A Study of Brexanolone for Acute Respiratory Distress Syndrome (ARDS) Due to Coronavirus Disease 2019 (COVID-19)

COVID-19 | Acute Respiratory Distress Syndrome

United States
Sage Therapeutics

Completed

A Study to Evaluate SAGE-547 in Participants With Severe Postpartum Depression

Severe Postpartum Depression

United States
Richard Crosby
Centers for Disease Control and Prevention

Completed

Assessing Repeat Fit Testing for CRC (ARFT)

Colo-rectal Cancer

United States
Russell Sage College

Completed

Effectiveness of Music Practical Examinations

Stress | Test Anxiety

United States
Sage Therapeutics

Completed

An Open-Label Study Evaluating Brexanolone in Adults With Tinnitus

Tinnitus

United States
Sage Therapeutics

Completed

A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Parkinson's Disease Mild Cognitive Impairment (PD-MCI)

Parkinson Disease | Cognitive Dysfunction

United States
Sage Therapeutics

Completed

Evaluate SAGE-547 in Participants With Essential Tremor

Essential Tremor

United States
Sage Therapeutics

Completed

Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status Epilepticus (SRSE)

Super-refractory Status Epilepticus

United States
Sage Therapeutics

Completed

A Study to Assess the Electrophysiology, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Response Using Magnetic Resonance Imaging of SAGE-718 Using a Ketamine Challenge in Healthy Subjects

Healthy Volunteer

United States
Sage Therapeutics

Completed

A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of SAGE-718 Oral Solution in Patients With Huntington's Disease - Part B

Huntington Disease

United States
Sage Therapeutics

Completed

A Study to Evaluate Efficacy and Safety of SAGE-547 in Participants With Severe Postpartum Depression (547-PPD-202B)

Postpartum Depression

United States
Sage Therapeutics

Completed

A Study With SAGE-547 for Super-Refractory Status Epilepticus

Super-Refractory Status Epilepticus

United States, Austria, Canada, Denmark, Estonia, Finland, France, Germany, Hungary, Israel, Italy, Netherlands, Serbia, Spain, Sweden, United Kingdom
Sage Therapeutics

Completed

Evaluate SAGE-547 in Female Participants With Severe Postpartum Depression

Postpartum Depression

United States

3

Subscribe